Loading
Cases by country, the UK and NHS pathway and other country lenses, the expert centres with trials on record, and the centres named on this cancer's subtypes.
No country-level case numbers. This cancer is not mapped to a GLOBOCAN site.
Baltimore · cancer center | United States | 0 | 2,962 | 42,161 | #10 | ||
Shanghai · hospital | China | none recorded | 0 | 2,872 | 31,534 | - | |
London · hospital | United Kingdom | none recorded | 0 | 1,946 | 24,827 | - | |
Naples · cancer center | Italy | none recorded | 0 | 979 | 17,774 | - | |
Portland, OR · cancer center | United States | 0 | 539 | 7,500 | - | ||
Brussels · cancer center | Belgium | none recorded | 0 | 469 | 8,888 | - | |
Montpellier · cancer center | France | 0 | 409 | 7,979 | - | ||
| Spain | none recorded | 0 | 403 | 4,139 | - | ||
Seoul · hospital | South Korea | none recorded | 0 | 371 | 2,001 | - | |
Kansas City, KS · cancer center | United States | 0 | 340 | 4,687 | - | ||
Candiolo · cancer center | Italy | none recorded | 0 | 327 | 4,568 | - | |
Lisbon · research institute | Portugal | none recorded | 0 | 297 | 6,938 | - | |
London · research institute | United Kingdom | none recorded | 0 | 245 | 3,596 | - | |
Hong Kong · hospital | Hong Kong SAR China | none recorded | 0 | 156 | 2,165 | - | |
Dundee · hospital | United Kingdom | none recorded | 0 | 145 | 1,003 | - |
These are the things we can measure; they are not a ranking of quality. Each column is a field on the institution record or a count over what OnCo has linked; a centre that treats many patients with Imatinib-resistant GIST but is thinly recorded here will look small.
Not known: OnCo holds no case-volume or outcome figures for centres, so none are shown. Where a national audit or registry publishes them, the centre's page links to it. Default order: Newsweek rank, then trials for this cancer, then research output.